SCM
MYOV

Sio Capital Management’s Myovant Sciences Ltd. MYOV Stock Holding History

Sio Capital Management’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-10,100
Closed -$142K – 111
2020
Q3 		$142K Buy
+10,100
New +$188K 0.03% 86
2018
Q1 		– Sell
-73,054
Closed -$923K – 51
2017
Q4 		$923K Buy
+73,054
New +$980K 0.52% 38

Other funds holding MYOV

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return

Sio Capital Management's MYOV Position: Q4 2020 in Review

Sio Capital Management sold out of Myovant Sciences Ltd. (MYOV) in Q4 2020, closing a stake of 10,100 shares — an estimated $142K sold.

Sio Capital Management first reported a position in MYOV in Q4 2017 and held it in 2 quarters. The position peaked at $923K in Q4 2017. 105 funds tracked by Wall St. Rank hold MYOV as of Q4 2020.

  • Sio Capital Management reported no remaining Myovant Sciences Ltd. position as of Q4 2020 after selling out during the quarter.
  • Sio Capital Management sold 10,100 Myovant Sciences Ltd. shares in Q4 2020, an estimated $142K.
  • Sio Capital Management first reported a position in Myovant Sciences Ltd. in Q4 2017 and held it in 2 quarters.
  • Sio Capital Management's Myovant Sciences Ltd. position peaked at $923K in Q4 2017.
  • 105 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2020.

Based on Sio Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.